Clinical Trial Update: Neuromodulation to Facilitate the Effect of Ketamine

View source ↗

Summary

A completed clinical trial evaluating whether neuromodulation enhances the effects of ketamine for depression, chronic pain, and substance use disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Pain
• Substance Use Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: The Neuroscience Center, LLC | Conditions: Depression, Chronic Pain | Status: COMPLETED